These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12079303)

  • 1. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression.
    Houle CD; Ding XY; Foley JF; Afshari CA; Barrett JC; Davis BJ
    Gynecol Oncol; 2002 Jul; 86(1):69-78. PubMed ID: 12079303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.
    Schindl M; Birner P; Breitenecker G; Oberhuber G
    Gynecol Oncol; 2001 Nov; 83(2):244-8. PubMed ID: 11606078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
    Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
    Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
    Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
    Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A; Lamb PW; Barrett JC
    Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.
    Liu FS; Chen JT; Dong JT; Hsieh YT; Lin AJ; Ho ES; Hung MJ; Lu CH
    Am J Pathol; 2001 Nov; 159(5):1629-34. PubMed ID: 11696423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
    Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
    Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
    Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.
    Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
    Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.
    Geradts J; Maynard R; Birrer MJ; Hendricks D; Abbondanzo SL; Fong KM; Barrett JC; Lombardi DP
    Am J Pathol; 1999 Jun; 154(6):1665-71. PubMed ID: 10362791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
    Jackson P; Ow K; Yardley G; Delprado W; Quinn DI; Yang JL; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(2):174-81. PubMed ID: 12806379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers.
    Guo XZ; Friess H; Maurer C; Berberat P; Tang WH; Zimmermann A; Naef M; Graber HU; Korc M; Büchler MW
    Cancer Res; 1998 Feb; 58(4):753-8. PubMed ID: 9485031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.